215 related articles for article (PubMed ID: 34541734)
21. Clinical characteristics of the patients with asymptomatic primary hyperparathyroidism.
Yao X; Jiang T; Wei B; Chang H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Apr; 46(4):368-372. PubMed ID: 33967082
[TBL] [Abstract][Full Text] [Related]
22. Sporadic and hereditary primary hyperparathyroidism.
Pepe J; Cipriani C; Pilotto R; De Lucia F; Castro C; Lenge L; Russo S; Guarnieri V; Scillitani A; Carnevale V; D'Erasmo E; Romagnoli E; Minisola S
J Endocrinol Invest; 2011 Jul; 34(7 Suppl):40-4. PubMed ID: 21985979
[TBL] [Abstract][Full Text] [Related]
23. Familial Hypocalciuric Hypercalcemia Types 1 and 3 and Primary Hyperparathyroidism: Similarities and Differences.
Vargas-Poussou R; Mansour-Hendili L; Baron S; Bertocchio JP; Travers C; Simian C; Treard C; Baudouin V; Beltran S; Broux F; Camard O; Cloarec S; Cormier C; Debussche X; Dubosclard E; Eid C; Haymann JP; Kiando SR; Kuhn JM; Lefort G; Linglart A; Lucas-Pouliquen B; Macher MA; Maruani G; Ouzounian S; Polak M; Requeda E; Robier D; Silve C; Souberbielle JC; Tack I; Vezzosi D; Jeunemaitre X; Houillier P
J Clin Endocrinol Metab; 2016 May; 101(5):2185-95. PubMed ID: 26963950
[TBL] [Abstract][Full Text] [Related]
24. Primary hyperparathyroidism in adults-(Part I) assessment and medical management: Position statement of the endocrine society of Australia, the Australian & New Zealand endocrine surgeons, and the Australian & New Zealand bone and mineral society.
Milat F; Ramchand SK; Herath M; Gundara J; Harper S; Farrell S; Girgis CM; Clifton-Bligh R; Schneider HG; De Sousa SMC; Gill AJ; Serpell J; Taubman K; Christie J; Carroll RW; Miller JA; Grossmann M
Clin Endocrinol (Oxf); 2024 Jan; 100(1):3-18. PubMed ID: 34931708
[TBL] [Abstract][Full Text] [Related]
25. Bone and primary hyperparathyroidism.
Cormier C; Koumakis E
Joint Bone Spine; 2022 Jan; 89(1):105129. PubMed ID: 33484857
[TBL] [Abstract][Full Text] [Related]
26. [Primary hyperparathyroidism].
Carnevale V; Romagnoli E; Pipino M; Scillitani A; D'Erasmo E; Minisola S; Mazzuoli G
Clin Ter; 2005; 156(5):211-26. PubMed ID: 16382970
[TBL] [Abstract][Full Text] [Related]
27. Characteristics, management, and outcome of primary hyperparathyroidism at a single clinical center from 2005 to 2016.
Sun B; Guo B; Wu B; Kang J; Deng X; Zhang Z; Fan Y
Osteoporos Int; 2018 Mar; 29(3):635-642. PubMed ID: 29198075
[TBL] [Abstract][Full Text] [Related]
28. Familial Hypocalciuric Hypercalcemia as an Atypical Form of Primary Hyperparathyroidism.
Marx SJ
J Bone Miner Res; 2018 Jan; 33(1):27-31. PubMed ID: 29115694
[TBL] [Abstract][Full Text] [Related]
29. Renal Dysfunction in Primary Hyperparathyroidism is associated with nephrolithiasis, elevated serum calcium-phosphate product and parathormone levels.
Banerjee M; Kar A; Ahamed J; Bhattacharjee R; Maitra D; Maisnam I; Das TC; Sahana PK; Chowdhury S; Mukhopadhyay S
Endocrine; 2024 Mar; 83(3):757-762. PubMed ID: 38091198
[TBL] [Abstract][Full Text] [Related]
30. Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods.
Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Brixen K; Mosekilde L
Clin Endocrinol (Oxf); 2008 Nov; 69(5):713-20. PubMed ID: 18410554
[TBL] [Abstract][Full Text] [Related]
31. Bone and Mineral Metabolism Phenotypes in MEN1-Related and Sporadic Primary Hyperparathyroidism, before and after Parathyroidectomy.
Marini F; Giusti F; Cioppi F; Maraghelli D; Cavalli T; Tonelli F; Brandi ML
Cells; 2021 Jul; 10(8):. PubMed ID: 34440663
[TBL] [Abstract][Full Text] [Related]
32. Further insights into the pathogenesis of primary hyperparathyroidism: a nested case-control study.
Rejnmark L; Amstrup AK; Mollerup CL; Heickendorff L; Mosekilde L
J Clin Endocrinol Metab; 2013 Jan; 98(1):87-96. PubMed ID: 23150677
[TBL] [Abstract][Full Text] [Related]
33. Genetic and clinical screening for hereditary primary hyperparathyroidism in a large Chinese cohort: a single-center study.
Song A; Yang Y; Jiang Y; Nie M; Jiang Y; Li M; Xia W; Xing X; Wang O
J Bone Miner Res; 2023 Sep; 38(9):1322-1333. PubMed ID: 37449924
[TBL] [Abstract][Full Text] [Related]
34. Primary hyperparathyroidism: Update on presentation, diagnosis, and management in primary care.
Pallan S; Khan A
Can Fam Physician; 2011 Feb; 57(2):184-9. PubMed ID: 21321169
[TBL] [Abstract][Full Text] [Related]
35. Classical and Nonclassical Manifestations of Primary Hyperparathyroidism.
El-Hajj Fuleihan G; Chakhtoura M; Cipriani C; Eastell R; Karonova T; Liu JM; Minisola S; Mithal A; Moreira CA; Peacock M; Schini M; Silva B; Walker M; El Zein O; Marcocci C
J Bone Miner Res; 2022 Nov; 37(11):2330-2350. PubMed ID: 36245249
[TBL] [Abstract][Full Text] [Related]
36. [Diagnostic evaluation and differential diagnosis of primary hyperparathyroidism].
Quesada Gómez JM
Endocrinol Nutr; 2009 Apr; 56 Suppl 1():14-9. PubMed ID: 19627756
[TBL] [Abstract][Full Text] [Related]
37. Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel inactivating mutations in an Italian population.
Stratta P; Merlotti G; Musetti C; Quaglia M; Pagani A; Izzo C; Radin E; Airoldi A; Baorda F; Palladino T; Leone MP; Guarnieri V
Nephrol Dial Transplant; 2014 Oct; 29(10):1902-9. PubMed ID: 25104082
[TBL] [Abstract][Full Text] [Related]
38. Primary Hyperparathyroidism: Effects on Bone Health.
Zanocco KA; Yeh MW
Endocrinol Metab Clin North Am; 2017 Mar; 46(1):87-104. PubMed ID: 28131138
[TBL] [Abstract][Full Text] [Related]
39. Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1.
Del Prete M; Marotta V; Ramundo V; Marciello F; Di Sarno A; Esposito R; Carratù AC; De Luca Di Roseto C; Di Somma C; Colao A; Faggiano A
Minerva Endocrinol; 2013 Dec; 38(4):389-94. PubMed ID: 24285106
[TBL] [Abstract][Full Text] [Related]
40. Management of familial hyperparathyroidism syndromes: MEN1, MEN2, MEN4, HPT-Jaw tumour, Familial isolated hyperparathyroidism, FHH, and neonatal severe hyperparathyroidism.
Cristina EV; Alberto F
Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):861-875. PubMed ID: 30665551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
